Accustem Sciences annual r&d spending
2021
2022
2023
2024
2025
Accustem Sciences R&D Spending Growth & History (ACUT)
Accustem Sciences's r&d spending was $281,014 for fiscal 2025.
View full Accustem Sciences company overviewAccustem Sciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $281,014 | $142,690 | +103.16% |
| 2024 | 2024-12-31 | $138,324 | −$1,339 | −0.96% |
| 2023 | 2023-12-31 | $139,663 | −$127,270 | −47.68% |
| 2022 | 2022-12-31 | $266,933 | $193,598 | +263.99% |
| 2021 | 2021-12-31 | $73,335 | — | — |
Accustem Sciences quarterly r&d spending
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $43,712 | −$16,492 | −27.39% |
| Q1 2026 | 2026-03-31 | $119,525 | $91,179 | +321.66% |
| Q4 2025 | 2025-12-31 | $119,744 | $77,772 | +185.29% |
| Q3 2025 | 2025-09-30 | $72,720 | $41,311 | +131.53% |
| Q2 2025 | 2025-06-30 | $60,204 | $18,458 | +44.22% |
| Q1 2025 | 2025-03-31 | $28,346 | $5,149 | +22.20% |
| Q4 2024 | 2024-12-31 | $41,972 | −$47,563 | −53.12% |
| Q3 2024 | 2024-09-30 | $31,409 | $11,458 | +57.43% |
| Q2 2024 | 2024-06-30 | $41,746 | $27,171 | +186.42% |
| Q1 2024 | 2024-03-31 | $23,197 | $7,595 | +48.68% |
| Q4 2023 | 2023-12-31 | $89,535 | −$43,589 | −32.74% |
| Q3 2023 | 2023-09-30 | $19,951 | −$38,319 | −65.76% |
| Q2 2023 | 2023-06-30 | $14,575 | −$39,821 | −73.21% |
| Q1 2023 | 2023-03-31 | $15,602 | −$5,541 | −26.21% |
| Q4 2022 | 2022-12-31 | $133,124 | $106,762 | +404.98% |
| Q3 2022 | 2022-09-30 | $58,270 | $44,145 | +312.53% |
| Q2 2022 | 2022-06-30 | $54,396 | $24,198 | +80.13% |
| Q1 2022 | 2022-03-31 | $21,143 | $18,493 | +697.85% |
| Q4 2021 | 2021-12-31 | $26,362 | — | — |
| Q3 2021 | 2021-09-30 | $14,125 | — | — |
| Q2 2021 | 2021-06-30 | $30,198 | — | — |
| Q1 2021 | 2021-03-31 | $2,650 | — | — |
Accustem Sciences r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Accustem Sciences's r&d spending increased from $73,335 to $281,014, a change of $207,679. The latest reported quarter, Q2 2026, shows $43,712.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Accustem Sciences source filings ↗